Home » Newsletters » BioWorld

BioWorld

March 20, 1997

View Archived Issues

OraVax's Stock Dives Nearly 50 Percent On Phase III Failure

Cloning GABA's Hidden Receptor Points To Psychoactive Drug Design

Protein Design Labs' Raises $73M In Public Offering

Other News to Note

Advanced Tissue Sciences Gets Skin Substitute Approval

Senate To Combine Bills For Drug User Fees, FDA Reform